Daniel Spiegelman
2013
In 2013, Daniel Spiegelman earned a total compensation of $4M as Executive Vice President, Chief Financial Officer at BioMarin Pharmaceutical, a 55% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $277,200 |
|---|---|
| Option Awards | $2,392,390 |
| Salary | $457,769 |
| Stock Awards | $895,092 |
| Other | $6,838 |
| Total | $4,029,289 |
Spiegelman received $2.4M in option awards, accounting for 59% of the total pay in 2013.
Spiegelman also received $277.2K in non-equity incentive plan, $457.8K in salary, $895.1K in stock awards and $6.8K in other compensation.
Rankings
In 2013, Daniel Spiegelman's compensation ranked 1,746th out of 12,286 executives tracked by ExecPay. In other words, Spiegelman earned more than 85.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,746 out of 12,286 | 86th |
Division Manufacturing | 572 out of 4,614 | 88th |
Major group Chemicals And Allied Products | 151 out of 1,466 | 90th |
Industry group Drugs | 101 out of 1,160 | 91st |
Industry Pharmaceutical Preparations | 88 out of 890 | 90th |
Source: SEC filing on April 25, 2016.
Spiegelman's colleagues
We found five more compensation records of executives who worked with Daniel Spiegelman at BioMarin Pharmaceutical in 2013.
2013
Jean-Jacques Bienaim
BioMarin Pharmaceutical
Chief Executive Officer
2013
Henry Fuchs
BioMarin Pharmaceutical
Chief Medical Officer
2013
Robert Baffi
BioMarin Pharmaceutical
Executive Vice President, Technical Operations
2013
G Davis
BioMarin Pharmaceutical
General Counsel
2013
Jeff Ajer
BioMarin Pharmaceutical